| 000 | 01647 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517152603.0 | ||
| 264 | 0 | _c20171012 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a2092-9382 | ||
| 024 | 7 |
_a10.3341/kjo.2015.0158 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSon, Bo Kwon | |
| 245 | 0 | 0 |
_aComparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion. _h[electronic resource] |
| 260 |
_bKorean journal of ophthalmology : KJO _cJun 2017 |
||
| 300 |
_a209-216 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFundus Oculi |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aMacula Lutea _xpathology |
| 650 | 0 | 4 |
_aMacular Edema _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRanibizumab _xadministration & dosage |
| 650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVisual Acuity |
| 700 | 1 | _aKwak, Hyung Woo | |
| 700 | 1 | _aKim, Eung Suk | |
| 700 | 1 | _aYu, Seung Young | |
| 773 | 0 |
_tKorean journal of ophthalmology : KJO _gvol. 31 _gno. 3 _gp. 209-216 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3341/kjo.2015.0158 _zAvailable from publisher's website |
| 999 |
_c27140889 _d27140889 |
||